RSV vaccine to protect infants gets green light from FDA advisors
Faint data signal of possible increased risk of premature birth caused some concern.

RSV vaccine to protect infants gets green light from FDA advisors
Faint data signal of possible increased risk of premature birth caused some concern.

No replies yet.